Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update
Greater 1-year and 2-year treatment continuation rates and longer median time to discontinuation for second-generation antipsychotic (SGA) long-acting injectables (LAIs) vs oral antipsychotics (OAPs) in Hungary were previously reported. This study reports an updated comparison between new LAIs vs OA...
Main Authors: | Balázs, T. (Author), Bitter, I. (Author), Czobor, P. (Author), FehCrossed D Sign©r, L. (Author), Hegyi, R. (Author), Kunovszki, P. (Author), Takács, P. (Author), Timtschenko, V. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Models of treatment with antipsychotics of the schizophrenic patients
by: Svjetlana Loga-Zec, et al.
Published: (2005-11-01) -
THE ROLE OF ATYPICAL ANTIPSYCHOTIC DECREASING AGGRESIVENESS IN SCHIZOPHRENIA
by: Juvita Novia Anggraini Maria
Published: (2013-03-01) -
A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers
by: Demet Sağlam Aykut, et al.
Published: (2018-07-01) -
Identification of Antipsychotic Side Effects with Glassgow Antipsychotic Side-Effect Scale (GASS)
by: Dita Hasni, et al.
Published: (2020-08-01) -
A comparative study on metabolic syndrome in patients with schizophrenia treated using first-generation and second-generation antipsychotics
by: Dinesh Panati, et al.
Published: (2020-01-01)